Find Reports
Select Report Type
Reimbursement Review
Displaying 1126 - 1150 of 1258
Please scroll or swipe to the right to view the full content.
| Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|
| Alsitek | masitinib mesylate | Amyotrophic lateral sclerosis (ALS) | Suspended | SR0766-000 | ||||
| Adcetris | brentuximab vedotin | Hodgkin lymphoma | Withdrawn | PC0311-000 | ||||
| Strattera | Atomoxetine hydrochloride | Attention deficit hyperactivity disorder | N/A | Complete | SF0085-000 | |||
| Raptiva | Efalizumab | Psoriasis, moderate to severe chronic plaque | N/A | Complete | SF0102-000 | |||
| Xyrem | Sodium oxybate | Narcolepsy | Withdrawn | SR0107-000 | ||||
| Celsentri | Maraviroc | HIV | Withdrawn | SR0113-000 | ||||
| N/A | naloxagol | Management of opioid-induced constipation (OIC). | Active | SX0753-000 | ||||
| Tremfya | guselkumab | Crohn’s disease | Pending | SR0882-000 | ||||
| Myfembree | relugolix, estradiol, and norethindrone acetate | Management of heavy menstrual bleeding associated with uterine fibroids | Pending | SR0885-000 | ||||
| Tagrisso | osimertinib | Unresectable (stage III) non-small cell lung cancer | Pending | PC0398-000 | ||||
| Verzenio | abemaciclib | HR-positive, HER2-negative advanced or metastatic breast cancer | Pending | PC0400-000 | ||||
| Tzield | teplizumab | Delay onset of Stage 3 Type 1 Diabetes | Pending | SR0867-000 | ||||
| Verzenio | abemaciclib | HR-positive, HER2-negative advanced or metastatic breast cancer | Pending | PC0409-000 | ||||
| Venclexta | venetoclax | Mantle cell lymphoma (MCL) | Pending | PC0402-000 | ||||
| Itovebi | inavolisib | Advanced or metastatic breast cancer | Pending | PC0382-000 | ||||
| TBC | tofersen | Amyotrophic lateral sclerosis (ALS) | Pending | SR0883-000 | ||||
| TBC | nemolizumab | atopic dermatitis | Pending | SR0869-000 | ||||
| TBC | mirvetuximab soravtansine | Epithelial ovarian, fallopian tube, or primary peritoneal cancer | Pending | PC0394-000 | ||||
| TBC | leniolisib | Activated phosphoinositide 3 kinase delta syndrome | Suspended | SR0792-000 | ||||
| TBC | rozanolixizumab | Generalized myasthenia gravis (gMG) | Active | SR0846-000 | ||||
| Talvey | talquetamab | Relapsed or refractory multiple myeloma | Active | PC0363-000 | ||||
| N/A | imiquimod | Gynecological cancers | Withdrawn | PX0364-000 | ||||
| N/A | Nab-paclitaxel | Gastrointestinal cancer | Do not reimburse | Complete | PX0354-000 | |||
| Tafinlar-Mekinist | dabrafenib trametinib | Advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation | Cancelled | PC0337-000 | ||||
| TBC | pegcetacoplan | Geographic atrophy secondary to age-related macular degeneration | Active | SR0810-000 |
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 1126 - 1150 of 2093
Please scroll or swipe to the right to view the full content.